Skip to main content
Explore our network
All sites

Novartis raises blockbuster drug forecasts to $18 billion as it seeks to prove growth can last

The drugmaker cited strong demand for its blockbuster drugs as it upgraded peak sales forecasts for multiple sclerosis, leukemia, and cholesterol medicines

Read full article at CNBC →

Originally published by CNBC. Summary and curation by DutyStation News.

📰 Related Stories

MAHA PAC spent more on steak, luxury club than candidates, report shows
📰 General

MAHA PAC spent more on steak, luxury club than candidates, report shows

Ars Technica25m ago
📰 General

Intuit to sell Mailchimp to Bending Spoons for $3.68 billion

CNBC26m ago
Just $161 reclaims all that space GTA VI stole on your PS5 with this M2 SSD deal
📰 General

Just $161 reclaims all that space GTA VI stole on your PS5 with this M2 SSD deal

9to5Google27m ago
Meta now sells 3D movies on Quest VR headsets
📰 General

Meta now sells 3D movies on Quest VR headsets

The Verge32m ago
Give your eyes (and wallet) the break they need with these TCL NXTPAPER Black Friday deals
📰 General

Give your eyes (and wallet) the break they need with these TCL NXTPAPER Black Friday deals

9to5Google1h ago
📰 General

What Ron Johnson's 'Ponzi scheme' label gets wrong about Social Security, experts say

CNBC1h ago
← Back to News
Novartis raises blockbuster drug forecasts to $18 billion as it seeks to prove growth can last — DutyStation News